Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T22:08:49.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:44:14.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:36:11.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.
    Difference
    2%
    Check dated 2024-12-07T15:49:56.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several links related to rare diseases and clinical trials have been removed, including key resources from NIH and Dailymed, which may impact access to important medical information.
    Difference
    3%
    Check dated 2024-11-23T04:28:53.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, with new resources added including links to clinical trials, disease information, and data download options, while the previous version v2.12.1 has been removed.
    Difference
    4%
    Check dated 2024-11-08T18:10:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.